Tianyin Pharmaceutical Co. Inc. (TPI) Posts Q2 FY2011 Financial Results
Tianyin Pharmaceutical Co. Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, today announced its financial results for the second quarter of fiscal year 2011. Revenue for the second quarter ended December 31, 2010, increased 69.6 percent to $25.3 million from $14.9 million in the second quarter of ended December 31, 2009. Cost of sales for the second quarter were $14.0 million, or 55.3 percent of sales, as compared to %7.2 million, or 48.3 percent of the sales quarter of 2009. Gross margin for the quarter ended December 31, 2010, was…